The FDA again adds more drugs to its valsartan recall list
date:Oct 26, 2018
FDA placed Zhejiang Huahai Pharmaceuticals on an import alert at the end of September, meaning all active pharmaceutical products and finished products made by the company will not be permitted to enter the US. The FDA made that decision after its recent inspection of the facility.

It's unclear exactly what the cancer risk is if you take the contaminated pills; the FDA believed the risk was low. It estimated that if 8,000 people took the highest dose of valsartan (320 mg) containing NDMA from t
4/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/30 19:09